國家衛生研究院 NHRI:Item 3990099045/12673
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 917839      在线人数 : 1301
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/12673


    题名: New classification may assist the development of targeted therapies for treatment-refractory castration-resistant prostate cancer
    作者: Lin, CY;Chuu, CP
    贡献者: Institute of Cellular and Systems Medicine
    摘要: For metastatic prostate cancer (PCa), the current standard treatment is androgen deprivation therapy (ADT). However, therapy-resistant tumors, named metastatic castration-resistant prostate cancer (mCRPC), recur in most ADT-treating patients within 3 years and the overall survival time is usually less than 2 years after the relapse (1,2). Docetaxel and two inhibitors targeting androgen receptor (AR) pathway, the abiraterone acetate and enzalutamide, are used for treatment of CRPC. The treatments increased survival as well as reduced pain and serum PSA level (3-6). However, a portion of CRPC patients receiving these drugs develop drug-resistance within a few months (7,8). New therapeutic strategies targeting the treatment-refractory mCRPC are therefore in need. Classification of cancers into subtypes with distinct histological and functional features may assist the development of new targeted therapies.
    日期: 2020-04
    關聯: Translational Andrology and Urology. 2020 Apr;9(2):837-839.
    Link to: http://dx.doi.org/10.21037/tau.2020.03.24
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=2223-4683&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000528242300075
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85085971051
    显示于类别:[褚志斌] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    ISI000528242300075.pdf201KbAdobe PDF362检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈